Description

The company is in the development phase of an innovative, patented drug for treating nocturia -- frequent urination at night. Currently there are no drugs on the market focused on nocturia, and the company plans to be first to market in the space. Over 100 million people in the US suffer from nocturia. Six patents have currently been issued.

Posted Jul 18, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.